Biomedical Occupation or Discipline – Page 29

FDA Greenlights Biocon Biologics and Biogen’s Eylea Biosimilars: A New Era in Ophthalmology

12 months ago talkbio0Tagged Biocon, Biogen, Biological Factors, Biosimilars, Eylea, Ophthalmology specialty, regulatory approval, United States Food and Drug Administration

FDA, Eylea, biosimilars, Biocon Biologics, Biogen, ophthalmology, aflibercept, regulatory approval

AstraZeneca’s Ambitious Vision: Pursuing $80 Billion in Revenue and 20 New Drugs by 2030

12 months ago talkbio0Tagged AstraZeneca, Biotechnology, Drug Development, Drug Industry, expansion, growth strategy, healthcare innovation, Market

AstraZeneca, revenue target, new drugs, 2030, growth strategy, pharmaceutical industry, healthcare innovation, biotechnology, drug development, market expansion.

Revolutionizing Drug Discovery: Sanofi, OpenAI, and Formation Bio Join Forces

12 months ago talkbio0Tagged Anabolism, Artificial Intelligence, Bio, Drug Development, Drug Discovery, healthcare innovation, OpenAI, Partnership, sanofi

Sanofi, OpenAI, Formation Bio, AI, drug development, partnership, drug discovery, pharmaceuticals, artificial intelligence, healthcare innovation.

AltruBio Secures $225M for Midphase Ulcerative Colitis Program Following Checkpoint Drug Modification

12 months ago talkbio0Tagged AltruBio, Biotechnology, checkpoint drug, Drug Development, healthcare innovation, midphase, midphase program, Ulcerative Colitis

AltruBio, checkpoint drug, ulcerative colitis, $225M funding, midphase program, biotechnology, drug development, healthcare innovation.

AstraZeneca Targets $80 Billion in Revenue by 2030: A Rapid Growth Trajectory

12 months ago talkbio0Tagged 2030, AstraZeneca, Drug Development, Drug Industry, growth trajectory, healthcare solutions

AstraZeneca, revenue target, 2030, growth trajectory, pharmaceutical industry, drug development, healthcare solutions.

Progentos Secures $65 Million for Groundbreaking Remyelination Therapy in Multiple Sclerosis Treatment

12 months ago talkbio0Tagged Biotechnology, Clinical Trials, Mississippi (geographic location), Multiple Sclerosis, nervous system repair, Neurodegenerative Disorders, Progentos, Remyelination

Progentos, funding, remyelination therapy, multiple sclerosis, MS treatment, clinical trials, neurodegenerative diseases, nervous system repair, biotechnology.

Rapport Neuroscience Biotech Aims for Expansion with Initial Public Offering

12 months ago talkbio0Tagged clinical-stage, expansion, IPO, mental health, nervous system disorder, Neuroscience discipline, Rapport

Rapport, neuroscience, biotech, IPO, clinical-stage, expansion, pharmaceuticals, neurological disorders, mental health

AstraZeneca Invests $1.5 Billion in Singapore for State-of-the-art Antibody-Drug Conjugate Manufacturing Facility

12 months ago talkbio0Tagged Antibody-Drug Conjugates, AstraZeneca, Biotechnology, Cancer Therapeutic Procedure, end-to-end, expansion, Facility (object), Generalized, innovation, Investments, Singapore

AstraZeneca, Singapore, investment, antibody-drug conjugate (ADC), manufacturing facility, end-to-end production, biotechnology, pharmaceuticals, cancer treatment, innovation, global expansion.